CA2193248C - Caplet and gelatin covering therefor - Google Patents
Caplet and gelatin covering therefor Download PDFInfo
- Publication number
- CA2193248C CA2193248C CA002193248A CA2193248A CA2193248C CA 2193248 C CA2193248 C CA 2193248C CA 002193248 A CA002193248 A CA 002193248A CA 2193248 A CA2193248 A CA 2193248A CA 2193248 C CA2193248 C CA 2193248C
- Authority
- CA
- Canada
- Prior art keywords
- shells
- caplet
- medicament
- land
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A medicament includes a caplet having a peripheral land which is inserted into mating capsule shell halves each with internally formed recesses defining external peripheral lands which align when the shell halves are fitted over the caplet.
In one embodiment of the invention, the internal diameter of the capsule shells is selected such that the caplet will fit within the capsule cell regardless of its orientation, while in another embodiment the caplet land mates with the internal recesses of the capsule shells. In a preferred embodiment of the invention, the capsule shells have different lengths and diameters such that one overlaps the other and can be sealed.
In one embodiment of the invention, the internal diameter of the capsule shells is selected such that the caplet will fit within the capsule cell regardless of its orientation, while in another embodiment the caplet land mates with the internal recesses of the capsule shells. In a preferred embodiment of the invention, the capsule shells have different lengths and diameters such that one overlaps the other and can be sealed.
Description
CAPLET AND GELATIN COVERING THEREFOR
BACKGROUND OF THE INVENTION
The present invention relates to a caplet shaped medicament and correspondingly shaped gelatin cover therefor.
Capsules have long been recognized as a preferred form of medicament for the delivery of active ingredients, which may take the form of powder, liquid, granules or a solid encapsulated capsule-like medicament. In view of the tamperability of conventional capsules made with hard-shell capsule halves of different diameters which can be taken apart, steps have been taken, including the banding of capsule halves to reduce the possibility of tampering. Although sealing of capsule shell halves, commonly referred to as belly-banding, has proven effective to prevent tampering and make tampering evident to the consumer. Solid dosage forms, which are coated to improve swallowability with a gelatin or other coating, provide a gelcap dosage form which further reduces tamperability. U.S. Patent Nos. 5,089,270; 5,213,738; 5,415,868; 4,820,524;
4,867,983; and 4,966,771 represent different approaches to providing a capsule-shaped product in the form of a caplet having a coating or covering which provides the appearance and, therefore, the consumer acceptability, of the popular capsule.
U.S. Patent Nos. 5,415,868 and 5,317,849 disclose different manners by which either hard shell capsule halves can be shrink-wrapped onto a caplet ('868), or a caplet core covered at opposite ends with a soft gelatin capsule shell half which is subsequently dried to simulate a capsule-like medicament ('849). U.S. Patent No. 5,464,631 suggests that studies have also shown the functional importance to consumers of providing a capsule-appearing solid dosage form which is multi-colored. The utilization of two colors can serve the function of identifying the type of medication, as well as providing a capsule-appearing product with a psychologically perceived medicinal efficacy.
Aesthetically, also, consumers apparently prefer the attractive appearance of mufti-colored capsules over single-colored capsules.
Thus, there has been an increase of activity by the pharmaceutical industry to provide over-the-counter caplet dosage forms which simulate the appearance of capsules and which have a variety of multiple colors which identify the type of medication provided so that the consumer can readily identify, for example, if the product is a particular type of analgesic or whether it includes antihistamines or other active ingredients in combination with analgesics. Such solid dosage forms have preferably been in the shape of a caplet and have been variously referred to as gelcaps or gel capsules and constitute solid caplet cores coated or covered with gelatin or other material. The above identified patents teach different approaches to providing the consumer with a capsule-appearing medicament; however, their manufacture requires either specialized manufacturing equipment or processes and tends to be somewhat expensive due to the manufacturing process. Also, when encapsulating a conventional, commercially available caplet which has sidewalk with conventional hard shell capsules, a uniform fit over the caplet cannot be achieved.
SUMMARY OF THE PRESENT INVENTION
In order to improve upon the uniformity of covering of a conventional caplet which by nature of its formation includes a longitudinally extending outwardly projecting land around its periphery, an improved hard shell capsule is provided which accommodates the conventional caplet shape and encapsulates the caplet to provide a medicament which conforms in appearance to a coated caplet and eliminates the need for expensive machinery and processes.
In a preferred embodiment of the invention, a medicament is provided which includes a conventional caplet having a peripheral land which is inserted into mating capsule shell halves each with internally formed recesses conforming to the shape of the land. In one embodiment of the invention, the internal diameter of the capsule shells is selected such that the caplet will fit within the capsule shells regardless of the mating of the caplet land with the internal recess of the capsule shells. In another embodiment, the capsule shells are dimensioned for receiving the caplet land for providing a closely fitting capsule shell and caplet. In a preferred embodiment of the invention, the capsule shells have different lengths such that one overlaps the other and can be sealed for safety. The resultant medicament provides an easily swallowed caplet with a covering allowing an improved mating fit with the caplet and which can be manufactured at a reasonable cost.
BACKGROUND OF THE INVENTION
The present invention relates to a caplet shaped medicament and correspondingly shaped gelatin cover therefor.
Capsules have long been recognized as a preferred form of medicament for the delivery of active ingredients, which may take the form of powder, liquid, granules or a solid encapsulated capsule-like medicament. In view of the tamperability of conventional capsules made with hard-shell capsule halves of different diameters which can be taken apart, steps have been taken, including the banding of capsule halves to reduce the possibility of tampering. Although sealing of capsule shell halves, commonly referred to as belly-banding, has proven effective to prevent tampering and make tampering evident to the consumer. Solid dosage forms, which are coated to improve swallowability with a gelatin or other coating, provide a gelcap dosage form which further reduces tamperability. U.S. Patent Nos. 5,089,270; 5,213,738; 5,415,868; 4,820,524;
4,867,983; and 4,966,771 represent different approaches to providing a capsule-shaped product in the form of a caplet having a coating or covering which provides the appearance and, therefore, the consumer acceptability, of the popular capsule.
U.S. Patent Nos. 5,415,868 and 5,317,849 disclose different manners by which either hard shell capsule halves can be shrink-wrapped onto a caplet ('868), or a caplet core covered at opposite ends with a soft gelatin capsule shell half which is subsequently dried to simulate a capsule-like medicament ('849). U.S. Patent No. 5,464,631 suggests that studies have also shown the functional importance to consumers of providing a capsule-appearing solid dosage form which is multi-colored. The utilization of two colors can serve the function of identifying the type of medication, as well as providing a capsule-appearing product with a psychologically perceived medicinal efficacy.
Aesthetically, also, consumers apparently prefer the attractive appearance of mufti-colored capsules over single-colored capsules.
Thus, there has been an increase of activity by the pharmaceutical industry to provide over-the-counter caplet dosage forms which simulate the appearance of capsules and which have a variety of multiple colors which identify the type of medication provided so that the consumer can readily identify, for example, if the product is a particular type of analgesic or whether it includes antihistamines or other active ingredients in combination with analgesics. Such solid dosage forms have preferably been in the shape of a caplet and have been variously referred to as gelcaps or gel capsules and constitute solid caplet cores coated or covered with gelatin or other material. The above identified patents teach different approaches to providing the consumer with a capsule-appearing medicament; however, their manufacture requires either specialized manufacturing equipment or processes and tends to be somewhat expensive due to the manufacturing process. Also, when encapsulating a conventional, commercially available caplet which has sidewalk with conventional hard shell capsules, a uniform fit over the caplet cannot be achieved.
SUMMARY OF THE PRESENT INVENTION
In order to improve upon the uniformity of covering of a conventional caplet which by nature of its formation includes a longitudinally extending outwardly projecting land around its periphery, an improved hard shell capsule is provided which accommodates the conventional caplet shape and encapsulates the caplet to provide a medicament which conforms in appearance to a coated caplet and eliminates the need for expensive machinery and processes.
In a preferred embodiment of the invention, a medicament is provided which includes a conventional caplet having a peripheral land which is inserted into mating capsule shell halves each with internally formed recesses conforming to the shape of the land. In one embodiment of the invention, the internal diameter of the capsule shells is selected such that the caplet will fit within the capsule shells regardless of the mating of the caplet land with the internal recess of the capsule shells. In another embodiment, the capsule shells are dimensioned for receiving the caplet land for providing a closely fitting capsule shell and caplet. In a preferred embodiment of the invention, the capsule shells have different lengths such that one overlaps the other and can be sealed for safety. The resultant medicament provides an easily swallowed caplet with a covering allowing an improved mating fit with the caplet and which can be manufactured at a reasonable cost.
According to an aspect of the present invention, there is provided a medicament comprising: a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally elongated body having a peripheral land extending around a center line thereof, and a gelatin cover for said caplet comprising two dissolvable shells, each with a longitudinally extending peripheral recess defining an external land and wherein an internal diameter of each of said shells is selected to receive said caplet with said peripheral recesses of said shells aligned with and extending over said peripheral land of said caplet, wherein said shells are shaped to conform to the external surface of said caplet.
According to an aspect of the present invention, there is provided a medicament comprising: a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally oval body including a flat side defining an outwardly extending peripheral land extending around a center line thereof; and a gelatin cover for said caplet comprising a pair of mating dissolvable shells, each with an enclosed end and an open end, each of said shells further including a longitudinally extending peripheral recess defining an external land and wherein said shells are dimensioned to conform to the external surface of said caplet and receive said caplet with said land of said caplet extending into said peripheral recesses of said shells.
These and other features, objects and advantages of the present invention will become apparent upon reading the following description thereof together with reference to ~e a~ompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a side elevational view of a caplet;
Fig. 2 is a top plan view of the caplet shown in Fig. 1;
Fig. 3 is a right-side view of the caplet shown in Fig. 2;
-2a-'' '~ 2193248 Fig. 4 is an exploded side elevational view of the capsule shells embodying the present invention;
Fig. 5 is a side elevational view of an assembled medicament embodying the present invention;
Fig. 6 is a vertical cross-sectional view of a medicament embodying the present invention showing a first orientation of the caplet within the capsule shells;
and Fig. 7 is a vertical cross-sectional view through a medicament embodying the present invention showing an alternate alignment of the caplet and capsule shells.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring initially to Figs. 1-3, there is shown a caplet 10 forming the core of a medicament 30 (Fig. 5) of the present invention. Caplet 10 is conventionally formed by pressing a blend of suitable active ingredients and excipients which may be either their natural color, including white, or can be conventionally colored as desired to provide a conventional, caplet-shaped core of any desired color. The active ingredients may be any analgesic such as acetylsalicylic acid, acetaminophen, ibuprofen or any other NSAID, which are commonly known and which can be pressed into the shape of a caplet utilizing conventional existing tableting equipment and processes. The caplet 10 may also exclusively include other active ingredients, such as antihistamines or a combination of analgesics and antihistamines, or other ingredients as is conventional. The caplet 10 includes a central body 12 having a generally elongated, somewhat oval shape, as seen in the top view of Fig. 2, and a horizontally extending peripheral land 14 extending around the central periphery of the caplet. This land is formed by the pressing process in conventional caplet-forming equipment where the caplet is pressed vertically, as seen in Fig. 1.
Typically, such caplets will be coated utilizing a dip or spray coating process for coating the caplet with any number of medicinally acceptable coverings such as gelatin, Opadry~, Providone~, methyl-cellulose, or other clear, film-forming materials which increase the swallowability of the caplet by providing a slippery covering to ease the physical swallowing process and also mask the taste of the ingredients which may be contained in the caplet. Instead of such a conventional coating, the caplet 10 of the present invention is encapsulated by the covering shown in Figs. 4-7, which covering comprises first and second shells 16 and 18, with shell 16 having a length somewhat greater than the shell 18 and dimensioned to fit within the end 20 of shell 18. Shells 16 . . ~ ~ 2~.~32.48 and 18 are made of a material which is dissolvable for exposing the caplet to the individual's digestive system and can be any medically suitable material with gelatin being preferred. Shell 16 includes a generally circular cross section having an internally formed recess 17 defining an externally extending land 19 conforming in appearance to land 14 of caplet 10. Capsule half 18 likewise has a generally circular cross section having an internal diameter slightly greater than the external diameter of capsule shell 16, and an internally extending recess 23 defining an outwardly extending land 21 conforming also to the general appearance of land 14 of caplet 10 shown in Figs. 1-3.
The capsule shells 16 and 18 are formed using conventional hard shell gelatin caplet forming equipment and processes, with the exception that the pins which are dip-coated with gelatin to form the caplet shells are shaped to define the outwardly extending lands 19 and 21 defining also the internal recesses 17 and 23, respectively.
In the preferred embodiment, the covers or shells 16 and 18 overlap as seen in Fig.
5, although in other embodiments it may be desirable to have the capsule shells of equal diameter and butt joined. To provide tamper resistance and evidence, a conventional gelatin band or seal 25 extends around the junction 24 of the completed medicament, as seen in Fig. 5, and seals the medicament. The internal diameter of the capsule cover 16 in the preferred embodiment is sufficient to allow the largest diameter portion of caplet 10 to orient itself within the capsule cover in any desired orientation, as seen in Fig. 6. Thus, the land 19 or 21 of the caplet cover 16 and 18, respectively, need not align with the land 14 of the caplet, as illustrated in Fig. 6. The resultant medicament tightly engages the edges of the caplet land 14 and has the swallowability of a coated caplet and a somewhat flatter appearance than a conventional capsule due to the lands 19 and 21 extending from the hard shell gelatin capsule halves 16 and 18.
The diameter of the capsule covers 16 and 18 can be selected to accommodate the caplet 10 in any orientation, as illustrated in Fig. 6, or if desired, can be selected such that the land 14 of the caplet 10 aligns with the internal recesses 17 and 23 of caplet covers 16 and 18, as seen in the cross section of Fig. 7. In this embodiment, it is necessary, however, to align the capsule covers 16 and 18 during assembly with the land 14 of the caplet. This can be accomplished with capsule loading equipment designed to orient the caplet 10 in predetermined relationship to each of the hard shell capsule covers 16 and 18, which are also aligned to overlap with the lands 19 and 21, overlapping and aligned as seen in Fig. 5.
According to an aspect of the present invention, there is provided a medicament comprising: a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally oval body including a flat side defining an outwardly extending peripheral land extending around a center line thereof; and a gelatin cover for said caplet comprising a pair of mating dissolvable shells, each with an enclosed end and an open end, each of said shells further including a longitudinally extending peripheral recess defining an external land and wherein said shells are dimensioned to conform to the external surface of said caplet and receive said caplet with said land of said caplet extending into said peripheral recesses of said shells.
These and other features, objects and advantages of the present invention will become apparent upon reading the following description thereof together with reference to ~e a~ompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a side elevational view of a caplet;
Fig. 2 is a top plan view of the caplet shown in Fig. 1;
Fig. 3 is a right-side view of the caplet shown in Fig. 2;
-2a-'' '~ 2193248 Fig. 4 is an exploded side elevational view of the capsule shells embodying the present invention;
Fig. 5 is a side elevational view of an assembled medicament embodying the present invention;
Fig. 6 is a vertical cross-sectional view of a medicament embodying the present invention showing a first orientation of the caplet within the capsule shells;
and Fig. 7 is a vertical cross-sectional view through a medicament embodying the present invention showing an alternate alignment of the caplet and capsule shells.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring initially to Figs. 1-3, there is shown a caplet 10 forming the core of a medicament 30 (Fig. 5) of the present invention. Caplet 10 is conventionally formed by pressing a blend of suitable active ingredients and excipients which may be either their natural color, including white, or can be conventionally colored as desired to provide a conventional, caplet-shaped core of any desired color. The active ingredients may be any analgesic such as acetylsalicylic acid, acetaminophen, ibuprofen or any other NSAID, which are commonly known and which can be pressed into the shape of a caplet utilizing conventional existing tableting equipment and processes. The caplet 10 may also exclusively include other active ingredients, such as antihistamines or a combination of analgesics and antihistamines, or other ingredients as is conventional. The caplet 10 includes a central body 12 having a generally elongated, somewhat oval shape, as seen in the top view of Fig. 2, and a horizontally extending peripheral land 14 extending around the central periphery of the caplet. This land is formed by the pressing process in conventional caplet-forming equipment where the caplet is pressed vertically, as seen in Fig. 1.
Typically, such caplets will be coated utilizing a dip or spray coating process for coating the caplet with any number of medicinally acceptable coverings such as gelatin, Opadry~, Providone~, methyl-cellulose, or other clear, film-forming materials which increase the swallowability of the caplet by providing a slippery covering to ease the physical swallowing process and also mask the taste of the ingredients which may be contained in the caplet. Instead of such a conventional coating, the caplet 10 of the present invention is encapsulated by the covering shown in Figs. 4-7, which covering comprises first and second shells 16 and 18, with shell 16 having a length somewhat greater than the shell 18 and dimensioned to fit within the end 20 of shell 18. Shells 16 . . ~ ~ 2~.~32.48 and 18 are made of a material which is dissolvable for exposing the caplet to the individual's digestive system and can be any medically suitable material with gelatin being preferred. Shell 16 includes a generally circular cross section having an internally formed recess 17 defining an externally extending land 19 conforming in appearance to land 14 of caplet 10. Capsule half 18 likewise has a generally circular cross section having an internal diameter slightly greater than the external diameter of capsule shell 16, and an internally extending recess 23 defining an outwardly extending land 21 conforming also to the general appearance of land 14 of caplet 10 shown in Figs. 1-3.
The capsule shells 16 and 18 are formed using conventional hard shell gelatin caplet forming equipment and processes, with the exception that the pins which are dip-coated with gelatin to form the caplet shells are shaped to define the outwardly extending lands 19 and 21 defining also the internal recesses 17 and 23, respectively.
In the preferred embodiment, the covers or shells 16 and 18 overlap as seen in Fig.
5, although in other embodiments it may be desirable to have the capsule shells of equal diameter and butt joined. To provide tamper resistance and evidence, a conventional gelatin band or seal 25 extends around the junction 24 of the completed medicament, as seen in Fig. 5, and seals the medicament. The internal diameter of the capsule cover 16 in the preferred embodiment is sufficient to allow the largest diameter portion of caplet 10 to orient itself within the capsule cover in any desired orientation, as seen in Fig. 6. Thus, the land 19 or 21 of the caplet cover 16 and 18, respectively, need not align with the land 14 of the caplet, as illustrated in Fig. 6. The resultant medicament tightly engages the edges of the caplet land 14 and has the swallowability of a coated caplet and a somewhat flatter appearance than a conventional capsule due to the lands 19 and 21 extending from the hard shell gelatin capsule halves 16 and 18.
The diameter of the capsule covers 16 and 18 can be selected to accommodate the caplet 10 in any orientation, as illustrated in Fig. 6, or if desired, can be selected such that the land 14 of the caplet 10 aligns with the internal recesses 17 and 23 of caplet covers 16 and 18, as seen in the cross section of Fig. 7. In this embodiment, it is necessary, however, to align the capsule covers 16 and 18 during assembly with the land 14 of the caplet. This can be accomplished with capsule loading equipment designed to orient the caplet 10 in predetermined relationship to each of the hard shell capsule covers 16 and 18, which are also aligned to overlap with the lands 19 and 21, overlapping and aligned as seen in Fig. 5.
~1932~8 Regardless of the orientation of the caplet in the capsule, the covers are shaped to include the longitudinally extending internal recess defining the external land having a height substantially the same or slightly greater than the height of the land 14 on a caplet.
The gelatin employed for the covers 16 and 18 can be a clear gelatin or colored in matching or different colors to provide the desired appearance of the resultant medicament to identify the medication contained within the cover and to provide a pleasing aesthetic appearance to the medicament. In one embodiment of the invention, the caplet 10 was an acetaminophen caplet with a length of .753 inches, a height of .24 inches and a land height of .096 inches. Gelatin shell 16 had a length of .646 inches, an internal diameter of .253 inches, an outer diameter of .261 inches and a recess height of .096 inches. Shell 18 had a length of .38 inches, an internal diameter of .264 inches, an outer diameter of .272 inches and a land height of .1 inches, such that caplet 10 fits relatively tightly within shell 16 which, in turn, fits within shell 18.
Thus, the medicament of the present invention provides a two-piece gelatin covering for a conventional caplet which conforms to the shape of the caplet and which can be sealed to provide tamper resistance and tamper evident protection for the consumer while providing an easy-to-swallow medicament.
It will become apparent to those skilled in the art that various modifications to the preferred embodiment of the invention as defined by the appended claims can be made without departing from the spirit or scope thereof as defined by the appended claims.
The gelatin employed for the covers 16 and 18 can be a clear gelatin or colored in matching or different colors to provide the desired appearance of the resultant medicament to identify the medication contained within the cover and to provide a pleasing aesthetic appearance to the medicament. In one embodiment of the invention, the caplet 10 was an acetaminophen caplet with a length of .753 inches, a height of .24 inches and a land height of .096 inches. Gelatin shell 16 had a length of .646 inches, an internal diameter of .253 inches, an outer diameter of .261 inches and a recess height of .096 inches. Shell 18 had a length of .38 inches, an internal diameter of .264 inches, an outer diameter of .272 inches and a land height of .1 inches, such that caplet 10 fits relatively tightly within shell 16 which, in turn, fits within shell 18.
Thus, the medicament of the present invention provides a two-piece gelatin covering for a conventional caplet which conforms to the shape of the caplet and which can be sealed to provide tamper resistance and tamper evident protection for the consumer while providing an easy-to-swallow medicament.
It will become apparent to those skilled in the art that various modifications to the preferred embodiment of the invention as defined by the appended claims can be made without departing from the spirit or scope thereof as defined by the appended claims.
Claims (10)
1. A medicament comprising:
a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally elongated body having a peripheral land extending around a center line thereof, and a gelatin cover for said caplet comprising two dissolvable shells, each with a longitudinally extending peripheral recess defining an external land and wherein an internal diameter of each of said shells is selected to receive said caplet with said peripheral recesses of said shells aligned with and extending over said peripheral land of said caplet, wherein said shells are shaped to conform to the external surface of said caplet.
a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally elongated body having a peripheral land extending around a center line thereof, and a gelatin cover for said caplet comprising two dissolvable shells, each with a longitudinally extending peripheral recess defining an external land and wherein an internal diameter of each of said shells is selected to receive said caplet with said peripheral recesses of said shells aligned with and extending over said peripheral land of said caplet, wherein said shells are shaped to conform to the external surface of said caplet.
2. The medicament as defined in claim 1 wherein one of said shells has a length and diameter different than the other of said shells, such that said shells overlap when fitted together with said external lands aligned and overlapping.
3. The medicament as defined in claim 2 wherein a junction of said shells is sealed with a gelatinous material.
4. The medicament as defined in claim 3 wherein one of said shells has a color different than the other of said shells.
5. A medicament comprising:
a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally oval body including a flat side defining an outwardly extending peripheral land extending around a center line thereof; and a gelatin cover for said caplet comprising a pair of mating dissolvable shells, each with an enclosed end and an open end, each of said shells further including a longitudinally extending peripheral recess defining an external land and wherein said shells are dimensioned to conform to the external surface of said caplet and receive said caplet with said land of said caplet extending into said peripheral recesses of said shells.
a solid caplet comprising a pressed mixture of excipients and active ingredients, said caplet including a generally oval body including a flat side defining an outwardly extending peripheral land extending around a center line thereof; and a gelatin cover for said caplet comprising a pair of mating dissolvable shells, each with an enclosed end and an open end, each of said shells further including a longitudinally extending peripheral recess defining an external land and wherein said shells are dimensioned to conform to the external surface of said caplet and receive said caplet with said land of said caplet extending into said peripheral recesses of said shells.
6. The medicament as defined in claim 5 wherein one of said shells has a length and diameter different than the other of said shells, such that said shells overlap when fitted together.
7. The medicament as defined in claim 6 wherein a junction of said shells is sealed with a gelatinous material.
8. The medicament as defined in claim 7 wherein one of said shells has a color different than the other of said shells.
9. The medicament as defined in claim 5 wherein a junction of said shells is sealed with a gelatinous material.
10. The medicament as defined in claim 9 wherein one of said shells has a color different than the other of said shells.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/699,450 US5824338A (en) | 1996-08-19 | 1996-08-19 | Caplet and gelatin covering therefor |
| US08/699,450 | 1996-08-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2193248A1 CA2193248A1 (en) | 1998-02-20 |
| CA2193248C true CA2193248C (en) | 2005-12-06 |
Family
ID=24809386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002193248A Expired - Fee Related CA2193248C (en) | 1996-08-19 | 1996-12-17 | Caplet and gelatin covering therefor |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US5824338A (en) |
| CA (1) | CA2193248C (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113945A (en) * | 1996-02-26 | 2000-09-05 | L. Perrigo Company | Multi-colored medicament |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| KR100827254B1 (en) | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | Methods and devices for providing prolonged drug therapy |
| USD430285S (en) * | 1999-04-16 | 2000-08-29 | Merck & Co., Inc. | Tablet |
| JP4993652B2 (en) * | 2004-03-31 | 2012-08-08 | リンテック株式会社 | Oral administration |
| US8268333B2 (en) | 2001-04-24 | 2012-09-18 | Lintec Corporation | Orally administered agent and an orally administered agent/supporting substrate complex |
| US6742646B2 (en) * | 2001-09-28 | 2004-06-01 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
| MXPA04002980A (en) * | 2001-09-28 | 2005-06-20 | Johnson & Johnson | Dosage forms having an inner core and outer shell with different shapes. |
| US6767200B2 (en) | 2001-09-28 | 2004-07-27 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
| US6982094B2 (en) | 2001-09-28 | 2006-01-03 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
| US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
| US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
| US7217381B2 (en) * | 2001-09-28 | 2007-05-15 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
| US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
| US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
| US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
| US7169450B2 (en) | 2002-05-15 | 2007-01-30 | Mcneil-Ppc, Inc. | Enrobed core |
| US6946156B2 (en) * | 2002-05-15 | 2005-09-20 | Mcneil-Ppc, Inc. | Process for enrobing a core |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| US20040081695A1 (en) * | 2002-09-28 | 2004-04-29 | Sowden Harry S | Dosage forms having an inner core and an outer shell |
| US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
| US20050074514A1 (en) * | 2003-10-02 | 2005-04-07 | Anderson Oliver B. | Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
| US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
| US8067029B2 (en) * | 2004-01-13 | 2011-11-29 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
| US20080102116A1 (en) * | 2004-09-13 | 2008-05-01 | Perrigo Company | Quick Dissolve Medicament and Method of Manufacturing |
| JP2008520726A (en) * | 2004-11-19 | 2008-06-19 | スミスクライン・ビーチャム・コーポレイション | Pharmaceutical products |
| DK1836665T3 (en) * | 2004-11-19 | 2013-04-15 | Glaxosmithkline Llc | PROCEDURE FOR SPECIAL CUSTOMIZED DELIVERY OF VARIABLE DOSAGE MEDICINE COMBINATION PRODUCTS FOR INDIVIDUALIZATION OF THERAPIES |
| US7404708B2 (en) * | 2004-12-07 | 2008-07-29 | Mcneil-Ppc, Inc. | System and process for providing at least one opening in dosage forms |
| US7530804B2 (en) * | 2004-12-07 | 2009-05-12 | Mcneil-Ppc, Inc. | System and process for providing at least one opening in dosage forms |
| US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
| US20070009573A1 (en) * | 2005-07-07 | 2007-01-11 | L N K International | Method of forming immediate release dosage form |
| WO2007062323A2 (en) * | 2005-11-18 | 2007-05-31 | Glaxo Group Limited | Machine and method for pharmaceutical and pharmaceutical-like product assembly |
| US20070190131A1 (en) * | 2006-02-10 | 2007-08-16 | Perry Ronald L | Press-fit rapid release medicament and method and apparatus of manufacturing |
| CA2647536C (en) * | 2006-03-28 | 2015-01-27 | Mcneil-Ppc, Inc. | Non-homogenous dosage form coatings |
| US20090110724A1 (en) * | 2007-10-31 | 2009-04-30 | Everett Laboratories, Inc. | Compositions and methods for treatment of pain |
| USD631537S1 (en) | 2009-09-15 | 2011-01-25 | Mcneil-Ppc, Inc. | Oral dosage form |
| USD666376S1 (en) * | 2010-12-01 | 2012-09-04 | Kraft Foods Global Brands Llc | Lozenge |
| USD666377S1 (en) * | 2010-12-01 | 2012-09-04 | Kraft Foods Global Brands Llc | Lozenge |
| USD755949S1 (en) | 2013-07-30 | 2016-05-10 | Reckitt Benckiser Llc | Tablet |
| USD741990S1 (en) | 2013-07-30 | 2015-10-27 | Reckitt Benckiser Llc | Tablet |
| USD787042S1 (en) * | 2015-04-28 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
| USD787043S1 (en) * | 2015-06-23 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
| USD835257S1 (en) | 2017-02-22 | 2018-12-04 | Celgene Corporation | Pharmaceutical tablet |
| USD813372S1 (en) | 2017-02-22 | 2018-03-20 | Celgene Corporation | Pharmaceutical tablet |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US462990A (en) * | 1891-11-10 | William oppenheimek | ||
| US2553071A (en) * | 1946-07-26 | 1951-05-15 | Robert H Van Sant | Dispensing package |
| US2584166A (en) * | 1948-05-25 | 1952-02-05 | Ayerst Mckenna & Harrison | Suppository |
| US4478596A (en) * | 1982-11-26 | 1984-10-23 | Michelson Paul E | Delivery system for physiologically active agents |
| US4478658A (en) * | 1982-12-20 | 1984-10-23 | Warner-Lambert Company | Method for sealing non-enteric capsules |
| US4773907A (en) * | 1982-12-20 | 1988-09-27 | Alza Corporation | Primary delivery system comprising secondary dosage form |
| US4883182A (en) * | 1985-05-31 | 1989-11-28 | Hughes Raymond J | Tamper evident capsule and insert device |
| US4928840A (en) * | 1986-02-25 | 1990-05-29 | American Home Products Corporation | Tamper proof encapsulated medicaments |
| US5074426A (en) * | 1986-11-13 | 1991-12-24 | Warner-Lambert Company | Dividable capsule |
| KR890003520Y1 (en) * | 1986-12-20 | 1989-05-27 | 주식회사 서흥캅셀 | Medicinal capsule |
| US4867983A (en) * | 1987-02-20 | 1989-09-19 | Mcneilab, Inc. | Method for double dipping gelating coated caplets |
| US4820524A (en) * | 1987-02-20 | 1989-04-11 | Mcneilab, Inc. | Gelatin coated caplets and process for making same |
| US4966771A (en) * | 1987-02-20 | 1990-10-30 | Mcneilab, Inc. | Gelatin coated caplets and process for making same |
| US5146730A (en) * | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
| US5089270A (en) * | 1990-05-15 | 1992-02-18 | L. Perrigo Company | Capsule-shaped tablet |
| US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
| US5464631A (en) * | 1990-06-27 | 1995-11-07 | Warner-Lambert Company | Encapsulated dosage forms |
| US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| US5317849A (en) * | 1992-08-07 | 1994-06-07 | Sauter Manufacturing Corporation | Encapsulation equipment and method |
| US5415868A (en) * | 1993-06-09 | 1995-05-16 | L. Perrigo Company | Caplets with gelatin cover and process for making same |
-
1996
- 1996-08-19 US US08/699,450 patent/US5824338A/en not_active Expired - Lifetime
- 1996-12-17 CA CA002193248A patent/CA2193248C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5824338A (en) | 1998-10-20 |
| CA2193248A1 (en) | 1998-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2193248C (en) | Caplet and gelatin covering therefor | |
| US5415868A (en) | Caplets with gelatin cover and process for making same | |
| US5464631A (en) | Encapsulated dosage forms | |
| US5198227A (en) | Dual subcoated simulated capsule medicament | |
| JP2939299B2 (en) | Undercoated capsule-like drug | |
| US6113945A (en) | Multi-colored medicament | |
| US5456919A (en) | Capsule and caplet combination | |
| US4928840A (en) | Tamper proof encapsulated medicaments | |
| US8858960B2 (en) | Method of producing a pharmaceutical product | |
| US5460824A (en) | Method for the preparation of an encapsulated medicament | |
| EP0435726B1 (en) | Capsule and caplet combination | |
| US20080102116A1 (en) | Quick Dissolve Medicament and Method of Manufacturing | |
| CA2643327A1 (en) | Press-fit rapid release medicament and method and apparatus of manufacturing | |
| JPS63135174A (en) | Freely dividable capsule | |
| NZ269094A (en) | Partially or wholly transparent soft gelatin capsule containing microbeadlets (which may also be enclosed in a hard shelled gelatin capsule) | |
| CA2117927C (en) | Caplets with gelatin cover and process for making same | |
| JP3877232B2 (en) | Caplet with gelatin cover and manufacturing method thereof | |
| CA2000348A1 (en) | Tamper proof encapsulated medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20151217 |